Silhouette

Trevor Martin Twose

Mithridion, Inc.

Employers

Affiliated Awards

Award Title Agency Phase Award amount Start Date End Date
Development of a Selective Muscarinic Agonist for the Treatment of Schizophrenia
Mithridion, Inc.
Principal Investigator
HHS 2 $447K 08/05/09 07/31/11
Development of a Selective Muscarinic Agonist for the Treatment of Schizophrenia
Mithridion, Inc.
Principal Investigator
HHS 2 $447K 12/19/08 07/31/09
Neuroprotective Drugs for Alzheimer's Disease
Mithridion, Inc.
Principal Investigator
HHS 1 $154K 08/01/06 01/31/08
Identification of Neuroactive Peptides protective against Alzheimer's disease
Mithridion, Inc.
Principal Investigator
HHS 1 $143K 08/01/06 01/31/08